推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Cancer Immunology Research

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER IMMUNOL 最新评论:请问你最后多久给的decision? (2024-08-02)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Cancer Immunology Research期刊基本信息Hello,您是该期刊的第59738位访客


基本信息 登录收藏
期刊名字Cancer Immunology ResearchCancer Immunology Research

CANCER IMMUNOL RES
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.9
51人评分
我要评分

声誉
10.0

影响力
7.9

速度
9.7

期刊ISSN2326-6066
微信扫码收藏此期刊
E-ISSN2326-6074
2023-2024最新影响因子
(数据来源于搜索引擎)
8.1 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:7.804
2023-2024自引率2.50%点击查看自引率趋势图
五年影响因子10.1
JCI期刊引文指标 1.93
h-index 62
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
15.603.7811.323
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q124 / 230
大类:Biochemistry, Genetics and Molecular Biology
小类:Immunology
Q128 / 236

期刊简介
Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.

Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.
期刊官方网站http://cancerimmunolres.aacrjournals.org/
期刊投稿网址https://cir.msubmit.net/cgi-bin/main.plex
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Immunology Research的语言要求,还能让Cancer Immunology Research编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Immunology Research编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
出版商American Association for Cancer Research Inc.
涉及的研究方向ONCOLOGY-IMMUNOLOGY
出版国家或地区UNITED STATES
出版语言English
出版周期
出版年份0
年文章数 114点击查看年文章数趋势图
Gold OA文章占比29.13%
研究类文章占比:
文章 ÷(文章 + 综述)
95.61%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:IMMUNOLOGYSCIEQ120/181
学科:ONCOLOGYSCIEQ135/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:IMMUNOLOGYSCIEQ115/181
学科:ONCOLOGYSCIEQ132/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区2区
IMMUNOLOGY
免疫学
4区2区1区
ONCOLOGY
肿瘤学
1区1区2区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区3区
IMMUNOLOGY
免疫学
1区1区1区
ONCOLOGY
肿瘤学
3区2区2区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区4区
IMMUNOLOGY
免疫学
3区1区2区
ONCOLOGY
肿瘤学
2区2区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2326-6066%5BISSN%5D
平均审稿速度网友分享经验:

平均录用比例网友分享经验:
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Cancer Immunology Research顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Cancer Immunology Research期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Cancer Immunology Research中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Cancer Immunology Research上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Science Immunology032.90
    Journal of Allergy and Clinical Immunology-In Practice4011.10
    npj Vaccines811.90
    OncoImmunology5812.80
    OncoImmunology4912.80
    ALLERGOLOGY INTERNATIONAL4512.60
    HLA933.00
    Immunity & Ageing3810.20
    Clinical and Translational Allergy287.50
    Immune Network1110.30
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE663015
    BIOMATERIALS557385
    BIOMEDICINE & PHARMACOTHERAPY536690
    Frontiers in Pharmacology503947
    Journal of Materials Chemistry B494597
    Frontiers in Immunology479851
    COMPUTERS IN BIOLOGY AND MEDICINE457614
    JOURNAL OF ETHNOPHARMACOLOGY454550
    COLLOIDS AND SURFACES B-BIOINTERFACES432411
    Frontiers in Oncology427220
  •  

    Cancer Immunology Research Cancer Immunology Research
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy

    Author: Xiao, Bo -Lin; Wang, Xiao-Le; Xia, Hou-Fu; Wang, Kui-Ming; Chen, Zhuo-Kun; Zhong, Ya-Hua; Jiang, Huan-Gang; Zhou, Fu-Xiang; Wang, Wei; Chen, Gai-Li; Chen, Gang
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 228-240. DOI: 10.1158/2326-6066.CIR-22-0277
        PubMed      DOI
    2.Extracellular Vesicle-Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis

    Author: Wang, Fang; Niu, Yuequn; Chen, Kelie; Yuan, Xiaoyu; Qin, Yuheng; Zheng, Fang; Cui, Zhenyan; Lu, Weiguo; Wu, Yihua; Xia, Dajing
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 199-216. DOI: 10.1158/2326-6066.CIR-22-0410
        PubMed      DOI
    3.HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells

    Author: Li, Lili; Hao, Shumin; Gao, Meiling; Liu, Junxiao; Xu, Xin; Huang, Jianfei; Cheng, Genhong; Yang, Heng
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 5, pp. 657-673. DOI: 10.1158/2326-6066.CIR-22-0317
        PubMed      DOI
    4.Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1-Independent Manner

    Author: Long, Yiru; Chen, Runqiu; Yu, Xiaolu; Tong, Yongliang; Peng, Xionghua; Li, Fanglin; Hu, Chao; Sun, Jianhua; Gong, Likun
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 2, pp. 241-260. DOI: 10.1158/2326-6066.CIR-22-0439
        PubMed      DOI
    5.Discovery of Podofilox as a Potent cGAMP-STING Signaling Enhancer with Antitumor Activity

    Author: Han, Jing; Hu, Shuiqing; Hu, Yawei; Xu, Yifang; Hou, Yanfei; Yang, Yinlong; Su, Huili; Zhang, Zhengyin; Liu, Peng; Sun, Xuxu; Zhang, Conggang
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 5, pp. 583-599. DOI: 10.1158/2326-6066.CIR-22-0483
        PubMed      DOI
    6.CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer

    Author: Wei, Ye; Xu, Tingting; Li, Chong; Zhou, Xin; Qian, Wei; Shen, Chunying; Wang, Qifeng; Xing, Xing; Ou, Xiaomin; He, Xiayun; Yin, Hongmei; Hu, Chaosu; Wang, Yu; Ji, Qinghai; Su, Fengtao; Lu, Xueguan
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 3, pp. 306-319. DOI: 10.1158/2326-6066.CIR-22-0454
        PubMed      DOI
    7.Cancer Cell Resistance to IFNg Can Occur via Enhanced Double-Strand Break Repair Pathway Activity

    Author: Han, Tong; Wang, Xujun; Shi, Sailing; Zhang, Wubing; Wang, Jue; Wu, Qiu; Li, Ziyi; Fu, Jingxin; Zheng, Rongbin; Zhang, Jiamin; Tang, Qin; Zhang, Peng; Wang, Chenfei
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 3, pp. 381-398. DOI: 10.1158/2326-6066.CIR-22-0056
        PubMed      DOI
    8.Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade

    Author: Yan, Bo; Hooper, D. Craig; Yuan, Zhiyong; Wang, Changli; Chen, Yulong; Lu, Bo
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 4, pp. 546-555. DOI: 10.1158/2326-6066.CIR-21-0839
        PubMed      DOI
    9.Tumor Cell-Derived Microparticles Induced by Methotrexate Augment T-cell Antitumor Responses by Downregulating Expression of PD-1 in Neutrophils

    Author: Xu, Pingwei; Zhang, Xiaojie; Chen, Kai; Zhu, Meng; Jia, Ru; Zhou, Qingwei; Yang, Jintao; Dai, Juqin; Jin, Yuepeng; Shi, Keqing
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 4, pp. 501-514. DOI: 10.1158/2326-6066.CIR-22-0595
        PubMed      DOI
    10.Herpes Virus Entry Mediator Costimulation Signaling Enhances CAR T-cell Efficacy Against Solid Tumors Through Metabolic Reprogramming

    Author: Sun, Shishuo; Huang, Chao; Lu, Mengmeng; Xu, Heng; Yuan, Yifan; Zhao, Wanxin; Hu, Xiaolei; Wang, Bixi; Zhang, Wei; Gao, Xiaoge; Zheng, Junnian; Su, Lishan; Zhang, Qing
    Journal: CANCER IMMUNOLOGY RESEARCH. 2023; Vol. 11, Issue 4, pp. 515-529. DOI: 10.1158/2326-6066.CIR-22-0531
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386173.60
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Materials61119.40
    Nature Reviews Disease Primers4876.70
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共81


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室